08 June 2021
The FDA will fully cooperate with the NBI on the alleged irregularities during inspection at Market Reach International Resources, Corp.
The FDA does not tolerate graft and corrupt practices. We are conducting a thorough investigation. If we find that there was a breach in protocol or any irregularities in enforcing the provisions of Republic Act No. 9711, we will pursue an administrative case.
The FDA will review its systems and procedures in collaborating with other government agencies as well as conducting and reporting of inspections.